Display options
Share it on

BMJ Open Diabetes Res Care. 2015 Feb 24;3(1):e000062. doi: 10.1136/bmjdrc-2014-000062. eCollection 2015.

Provider beliefs about diabetes treatment have little impact on glycemic control of their patients with diabetes.

BMJ open diabetes research & care

Erin S LeBlanc, A Gabriela Rosales, Sumesh Kachroo, Jayanti Mukherjee, Kristine L Funk, Jennifer L Schneider, Gregory A Nichols

Affiliations

  1. Kaiser Permanente Center for Health Research , Portland, Oregon , USA.
  2. Bristol-Myers Squibb , Wallingford, Connecticut , USA.

PMID: 25741443 PMCID: PMC4342519 DOI: 10.1136/bmjdrc-2014-000062

Abstract

OBJECTIVE: To improve the health of people with diabetes, it is essential to identify why patients experience extended periods of poor glycemic control before therapeutic intensification.

RESEARCH DESIGN AND METHODS: We surveyed 252 primary care providers at Kaiser Permanente Northwest to determine their beliefs about the glycemic goals of their patients, treatment intensification behavior, and barriers to achieving optimal glycemic control. We linked the responses of 149 providers to the health records of their 18 346 patients with diabetes.

RESULTS: Patient glycemic levels were not related to either individualized glycemic goals or provider intensification behavior. Providers' beliefs about diabetic treatment and glycated hemoglobin (HbA1c) goals were poorly associated with patient HbA1c levels. Providers identified patients' resistance to lifestyle behaviors and taking insulin, lack of medication adherence, and psychosocial issues as the main barriers to optimal glycemic control. Lack of time to care for complex patients was also a barrier. Providers who agreed that "current research did not support A1C levels <7%" were less likely to have patients with HbA1c levels <7% (OR=0.87, 95% CI 0.78 to 0.97) and patients of providers who disagreed that "some patients will have an A1C >9% no matter what I do" were 16% more likely to have patients with HbA1c <7% (1.16, 1.03 to 1.30) compared with providers who were neutral about those statements.

CONCLUSIONS: Given the consistency of HbA1c levels across providers despite differences in beliefs and intensification behaviors, these barriers may be best addressed by instituting changes at the system level (ie, instituting institutional glycemic targets or outreach for dysglycemia) rather than targeting practice patterns of individual providers.

Keywords: Health Services

References

  1. Diabetes Care. 2013 Jan;36 Suppl 1:S11-66 - PubMed
  2. Diabetes. 1995 Nov;44(11):1249-58 - PubMed
  3. Am J Med. 2013 Sep;126(9 Suppl 1):S38-48 - PubMed
  4. Diabetes Care. 2004 Jul;27(7):1535-40 - PubMed
  5. Diabetes Metab. 2011 Nov;37 Suppl 3:S27-38 - PubMed
  6. Diabetes Care. 2012 Mar;35(3):495-7 - PubMed
  7. Diabetes Care. 2013 Aug;36(8):2271-9 - PubMed
  8. Curr Med Res Opin. 2010 Sep;26(9):2127-35 - PubMed
  9. Diabet Med. 2005 Oct;22(10):1379-85 - PubMed
  10. Arch Intern Med. 2011 Sep 26;171(17):1542-50 - PubMed
  11. Ann Intern Med. 2012 Feb 7;156(3):218-31 - PubMed
  12. Endocr Pract. 2007 Jan-Feb;13(1):37-44 - PubMed
  13. Ann Intern Med. 2001 Nov 6;135(9):825-34 - PubMed
  14. Diabetes Res Clin Pract. 2014 Mar;103(3):402-11 - PubMed
  15. Endocr Pract. 2013 Mar-Apr;19(2):327-36 - PubMed
  16. Diabetes Care. 2009 Jan;32(1):193-203 - PubMed
  17. Diabetes Care. 2013 Nov;36(11):3411-7 - PubMed
  18. Diabet Med. 2004 Feb;21(2):150-5 - PubMed
  19. Ann Fam Med. 2007 May-Jun;5(3):196-201 - PubMed
  20. Diabetes Care. 2012 Dec;35(12):2650-64 - PubMed
  21. Diabetes Care. 2010 Mar;33(3):501-6 - PubMed
  22. Diabetes Educ. 2005 Jul-Aug;31(4):564-71 - PubMed
  23. Diabetes Res Clin Pract. 2013 Feb;99(2):174-84 - PubMed
  24. Diabetes Care. 2005 Mar;28(3):600-6 - PubMed

Publication Types